US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

del Nido Cardioplegia Solution

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0151-2020
Class II · Moderate risk Terminated

Amino Acid Injection 50 g/1000 mL

Reason Lack of Assurance of Sterility; bags have potential to leak

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center D-0150-2020
Class II · Moderate risk Terminated

PF-Fentanyl Citrate

Reason GMP Deviations: potential glass contamination

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center NDC 69374-0525-25 D-0147-2020
Class II · Moderate risk Terminated

Leucovorin Calcium Injection

Reason Crystallization: Presence of particulate matter identified as API crystallization

Ingenus Pharmaceuticals Llc NDC 50742-464-50 D-0146-2020
Class II · Moderate risk Terminated

Rifampin for Injection

Reason Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Mylan Laboratories Limited (Sterile Products Division) NDC 67457-445-60 D-0139-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. D-0185-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 63868-480-24 D-0184-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 0363-0131-30 D-0183-2020
Class II · Moderate risk Completed

Dr. Reddy's Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 55111-404-34 D-0182-2020
Class II · Moderate risk Completed

Dr. Reddy's Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 55111-131-60 D-0181-2020
Class II · Moderate risk Completed

Dr. Reddy's Ranitidine Capsules

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 55111-130-30 D-0180-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 11673-849-40 D-0179-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. D-0178-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 71713-203-02 D-0177-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 43598-808-62 D-0176-2020
Class II · Moderate risk Completed

Ranitidine Tablets 75 mg

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 63868-482-30 D-0175-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 30142-131-30 D-0174-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 69842-871-30 D-0173-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 30142-505-34 D-0172-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 49035-404-61 D-0171-2020
Class II · Moderate risk Completed

Ranitidine Tablets

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Dr. Reddy's Laboratories, Inc. NDC 0363-0010-34 D-0170-2020